Versatility of Autologous Growth Factor Concentrate Therapy in Early-Stage Androgenetic Alopecia: A Case Report

    Abhijeet Ingle, Sapna Tandon, Himanshu Chauhan, Hemant Mehra, Garima Tiwari
    Image of study
    TLDR Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.
    This case report presents autologous growth factor concentrate (GFC) therapy as a promising treatment for early-stage androgenetic alopecia (AGA) in a 28-year-old male. After four monthly GFC sessions, the patient experienced a 36% increase in hair density and an 18% increase in hair shaft thickness, with no adverse effects and high satisfaction. GFC, a leukocyte-free, platelet-derived product, offers a safe and effective alternative to conventional treatments like minoxidil and finasteride. While the results are promising, further studies with larger sample sizes are needed to confirm long-term efficacy and optimize treatment protocols.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 12 results

    Related Research

    1 / 1 results